Newbridge Financial Services Group, Inc. Acadia Pharmaceuticals Inc Transaction History

Newbridge Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$16.79 - $27.09 $2,518 - $4,063	-150 Reduced 68.18%	70 $2,000
Q3 2021 Oct 27, 2021	SELL	$15.78 - $24.77 $2,367 - $3,715	-150 Reduced 40.54%	220 $4,000
Q1 2021 Sep 07, 2021	BUY	$25.02 - $54.99 $1,751 - $3,849	70 Added 23.33%	370 $10,000
Q3 2020 Sep 07, 2021	BUY	$36.42 - $57.0 $10,926 - $17,100	300 New	300 $12,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.